News

Leadership Transition at Cetera: Tom Gooley's Retirement Moments

Leadership Transition at Cetera: Tom Gooley's Retirement Moments

Tom Gooley's Retirement Marks New Chapter for Cetera

After a successful tenure, Chief Operating Officer Tom Gooley is set to retire, concluding a remarkable journey filled with innovation and leadership at Cetera Financial Group. His planned transition caps off a significant period for the organization while establishing a strong foundation for the future.

A Legacy of Leadership and Growth

Gooley's strategic planning for his retirement demonstrates his commitment to maintaining stability during a critical time for the company. With a legacy built on excellence across the financial services sector, he has significantly contributed to Cetera's growth trajectory since joining the firm in late 2020.

Ensuring Stability During Transition

As Gooley prepares for retirement, he will continue to oversee operations through early 2026. This carefully timed departure allows him to support ongoing initiatives, including the integration of Avantax services. His collaboration with the leadership team exemplifies a strong commitment to ensuring continuity for both advisors and internal teams at Cetera.

The Impact of Tom Gooley's Leadership

Mike Durbin, CEO of Cetera Financial Group, highlighted Gooley's immense contributions, stating, "Tom's leadership was crucial in establishing our powerful position within the industry." His ability to steer the organization through vital transitions has not only improved operational consistency but also positively influenced the careers of many within Cetera.

A Journey Through Leadership Roles

Before joining Cetera, Gooley accumulated valuable experience at prominent firms such as Goldman Sachs and LPL Financial. His exposure to multiple financial environments equipped him with unique insights that propelled Cetera forward, particularly during its significant expansions.

Driving Customer-Centric Innovation

During his time at Cetera, Gooley emphasized the importance of delivering a customer-centric experience. Under his guidance, the company launched a multi-custodial platform that included key partnerships, showcasing the innovative approach that enables Cetera to provide tailored solutions for advisors.

Forward-Looking Vision

Reflecting on his journey, Gooley expressed pride in the collaborative successes achieved by the team. "We've built a strong foundation rooted in trust and teamwork," he remarked, underlining the culture of shared ownership that drives high performance within Cetera.

Looking Ahead: A New Leadership Era

Cetera is preparing to announce Gooley's successor, an experienced leader poised to take the helm and continue the momentum established. Gooley's involvement in onboarding the new leader will ensure a smooth transition and maintain the benefits derived from Cetera's scale while catering to the unique needs of each advisor and financial institution.

A Celebration of Legacy

This transition signifies not just a farewell but a celebration of Gooley's impactful journey. As he and the leadership team reflect on the progress made, they look forward to the future with optimism, ensuring that Cetera remains a leader in delivering exceptional value to its advisors.

About Cetera Financial Group

Cetera Financial Group stands as a dynamic force in the financial advisory space, offering cutting-edge support and various affiliation models for independent advisors. With a robust network that includes around 12,000 advisors, Cetera facilitates growth and transformation tailored to individual needs. The company's commitment to delivering superior solutions is evident, highlighted by its impressive scores from client feedback and industry accolades.

Frequently Asked Questions

1. What is the significance of Tom Gooley's retirement?

His retirement marks the end of a successful operation period for Cetera and ensures a structured transition to new leadership.

2. How did Tom Gooley contribute to Cetera's growth?

Gooley successfully oversaw critical initiatives like the Avantax integration, enhancing operational efficiency and customer satisfaction.

3. Who will replace Tom Gooley as COO?

Cetera Financial Group is in the process of announcing a qualified successor to continue the company's positive growth trajectory.

4. What is Cetera's approach to supporting advisors?

Cetera prioritizes personalized support and flexible models to empower advisors and enhance their business growth opportunities.

5. How does Cetera manage to stand out in the financial services industry?

By blending modern technology with a community-driven culture, Cetera offers unique solutions tailored to advisors' needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 28

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 26

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 34

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 32

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 23

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

TKO Group Launches Major Share Buyback and Dividend Initiative

Updated Category News Views 669

TKO Group Announces Strategic Financial Moves TKO Group Holdings, Inc. (NYSE: TKO) has recently made headlines with its announcement of a remarkable share repurchase program amounting to $2 billion. Alongside this significant initiative, the company is introducing a quarterly cash dividend that is projected to reach $75 million. These strategic financial maneuvers reflect...

Continue Reading
An Insightful Look at Warner Bros. Discovery's Declining Short Interest

Updated Category News Views 64

Understanding Warner Bros. Discovery's Short Interest Trends Warner Bros. Discovery (WBD) has seen a noteworthy drop in its short percent of float, falling by 11.22% since the last report. Currently, the company reports that there are 101.75 million shares sold short, representing about 4.67% of all available shares for trading. Interestingly, based on the current trading...

Continue Reading
Avobis Bio Advances Clinical Trials for Innovative Therapy Solutions

Updated Category News Views 185

Avobis Bio Unveils Breakthrough in Clinical Trial for AVB-114 Avobis Bio LLC, a pioneering company focused on developing innovative implantable cell therapies, has made a remarkable stride by completing the primary analysis of the STOMP-II randomized clinical trial targeting Crohn's perianal fistulas. This analysis brings with it exciting prospects for FDA interaction and...

Continue Reading
Innovative Bait Accessory Enhances Fishing Experience

Updated Category News Views 239

Revolutionizing Fishing with a New Bait Accessory Fishing is more than just a hobby; it's a passion for many outdoor enthusiasts. That's why the recent invention of the E Z BAIT accessory is creating waves in the angling community. Designed for all fishing lovers, it aims to keep your bait right where you need it without missing a beat. Convenience at Your Fingertips...

Continue Reading
Oncoinvent ASA: Advancing Cancer Therapies with Financial Focus

Updated Category News Views 158

Oncoinvent ASA's Periodic Performance Highlights Oncoinvent is making strides in the oncology sector, particularly with its Phase 2 trial for ovarian cancer. This clinical-stage biotechnology company is diligently focusing on expanding its research scope while ensuring sound financial management practices. Their primary product, Radspherin®, is a radiopharmaceutical...

Continue Reading